Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable synchromed pumps

Neurosurgery

Volumn 55, Issue 2, 2004, Pages 390-393

  Taha, Jamal ^a,e   Favre, Jacques ^b   Janszen, Michele ^a   Galarza, Marcelo ^c   Taha, Assad ^d  

^a KETTERING MEDICAL CENTER   (United States)

^b Montreux Hospital   (Switzerland)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^e Taha Neurosurgical Clinic   (United States)

Author keywords

Failed back syndrome; Intrathecally administered drug therapy; Morphine; Pain modulation; Pump

Indexed keywords

ANALGESIC AGENT; BACLOFEN; BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; MORPHINE;

ADULT; AGED; ARACHNOIDITIS; CHRONIC PAIN; CHRONIC PANCREATITIS; DEVICE INFECTION; DRUG MONITORING; DRUG USE; FEMALE; HUMAN; INFUSION PUMP; MALE; MINIPUMP; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SPASTICITY; SYMPTOM; UNITED STATES; WITHDRAWAL SYNDROME;

EID: 3543008919     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000129698.73730.e4     Document Type: Review

References (2)

1. Green LB, Nelson VS: Death after acute withdrawal of intrathecal badofen: Case report and literature review. Arch Phys Med Rehabil 80:1600-1604, 1999
2. Implantation of SynchroMed Pump. Minneapolis, Medtronic Publication.